Cassava Sciences Inc vs Monster Beverage Corp — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Monster Beverage Corp trades at $45.62 (market cap $89.20B). The key difference: Monster Beverage Corp is far larger — about 1868.1× Cassava Sciences Inc's market cap, and Monster Beverage Corp is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MNST | |
|---|---|---|
Market Cap | $47.75M | $89.20B |
Sector | Health | Consumer Staples |
52-Week High | $4.64 | $49.97 |
52-Week Low | $0.87 | $30.86 |
Enterprise Value | -$34.93M | $87.49B |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →